Human 5-HT3A -- Phe 221

Species Original Mutated to Mutation
Human Phe 221  

 

Rat Equivalent Phe 226    
Mouse Equivalent Phe 226

Ala

Tyr

F226A

F226Y

 

mPhe226Ala

In this study amino acids from E225 to Y234 of a murine 5-HT3ASR were individually mutated to alanine. Conservative mutations were made if the initial alanine mutation showed no binding and/or function. The mutated receptors were evaluated using radioligand binding, two-electrode voltage clamp, and immunofluorescence studies.

The F226A mutation did not cause any significant changes in the Kd value for [3H]granisetron, but did significantly change Bmax. There was a 200-fold reduction in the Ki value for 5-HT. There was a 40-fold reduction in the Ki value for mCPBG. The EC50 value could not be determined as the receptor was not funcitonal.

Suryanarayanan A, Joshi PR, Bikádi Z, Mani M, Kulkarni TR, Gaines C, Schulte MK. (2005) The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide. Biochemistry 44(25):9140-9.

back to top
back to 5-HT3A

 

Twenty six residues (I71, Y73,W90, R92, N128, E129, Y143, Y153, T179, T181, S182,W183, L184, W195, V201, R202, S203, S206, I207, F226, I228, D229, I230, Y234, E236, K238) were replaced by either alanine or a residue with similar physicochemical properties to the native residue, to examine their roles in docking of [3H]granisetron into the 5-HT3A receptor binding site. Mouse 5-HT3A receptors were expressed in HEK293 cells and homology modeling, ligand-docking and radioligand binding were used.

The F226A and F226Y mutations did not significantly alter the affinity of the antagonist [3H]granisetron. The table below lists conservative and non-conservative substitutions that either both, or individually affected [3H]granisetron binding.

Receptor [3H]granisetron binding (Kd)
WT 0.31+/-0.04
W90A*

NB

W90Y* 0.90 +/- 0.06
R92A* 1.80 +/- 0.40
R92K 1.00 +/- 0.30
E129A* NB
E129D* NB
Y153A* 2.36 +/- 0.53
Y153F 0.90 +/- 0.20
T179A* 3.20 +/- 0.10
T179S 0.38 +/- 0.20
S181A* 0.12 +/- 0.04
S181S 0.58 +/- 0.10
S182A* 1.00 +/- 0.20
S182T* 1.80 +/- 0.09
W183A*/Y* NB
L184A* 4.11 +/- 0.94
L184I* 0.71 +/- 0.05
W195A* 5.08 +/- 0.88
W195Y* 8.70 +/- 2.40
S203A* 0.08 +/-0.02
S203T 0.26 +/- 0.11
S206A* 1.67 +/- 0.27
S206T* 4.40 +/- 0.49
I228A* 1.40 +/- 0.30
I228N 0.30 +/- 0.05
D229A* 3.80 +/- 0.26
D229E* 0.11 +/- 0.03
I230A 0.30 +/- 0.10
I230N* 1.70 +/- 0.40
Y234A* NB
Y234F 1.30 +/- 0.36

NB, No binding

* significantly different from the WT 5-HT3A receptor

Thompson AJ, Price KL, Reeves DC, Chan SL, Chau PL, Lummis SC(2005). Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding.The Journal of Biological Chemistry 280(21):20476-82

back to top
go back to 5-HT3A

 

mPhe226Tyr

In this study amino acids from E225 to Y234 of a murine 5-HT3ASR were individually mutated to alanine. Conservative mutations were made if the initial alanine mutation showed no binding and/or function. The mutated receptors were evaluated using radioligand binding, two-electrode voltage clamp, and immunofluorescence studies.

The F226Y mutation did not cause any significant changes to either the Kd value for [3H]granisetron or the Bmax value. There was a 185-fold reduction in the Ki value for 5-HT, with a 7.4-fold reduction in the EC50 value and a significant decrease in Imax. There was a 28-fold reduction in the Ki value for mCPBG, with an 8.5-fold reduction in the EC50 value and a significant decrease in Imax.

Suryanarayanan A, Joshi PR, Bikádi Z, Mani M, Kulkarni TR, Gaines C, Schulte MK. (2005) The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide. Biochemistry 44(25):9140-9.

back to top
back to 5-HT3A

 

Twenty six residues (I71, Y73,W90, R92, N128, E129, Y143, Y153, T179, T181, S182,W183, L184, W195, V201, R202, S203, S206, I207, F226, I228, D229, I230, Y234, E236, K238) were replaced by either alanine or a residue with similar physicochemical properties to the native residue, to examine their roles in docking of [3H]granisetron into the 5-HT3A receptor binding site. Mouse 5-HT3A receptors were expressed in HEK293 cells and homology modeling, ligand-docking and radioligand binding were used.

The F226A and F226Y mutations did not significantly alter the affinity of the antagonist [3H]granisetron. The table below lists conservative and non-conservative substitutions that either both, or individually affected [3H]granisetron binding.

Receptor [3H]granisetron binding (Kd)
WT 0.31+/-0.04
W90A*

NB

W90Y* 0.90 +/- 0.06
R92A* 1.80 +/- 0.40
R92K 1.00 +/- 0.30
E129A* NB
E129D* NB
Y153A* 2.36 +/- 0.53
Y153F 0.90 +/- 0.20
T179A* 3.20 +/- 0.10
T179S 0.38 +/- 0.20
S181A* 0.12 +/- 0.04
S181S 0.58 +/- 0.10
S182A* 1.00 +/- 0.20
S182T* 1.80 +/- 0.09
W183A*/Y* NB
L184A* 4.11 +/- 0.94
L184I* 0.71 +/- 0.05
W195A* 5.08 +/- 0.88
W195Y* 8.70 +/- 2.40
S203A* 0.08 +/-0.02
S203T 0.26 +/- 0.11
S206A* 1.67 +/- 0.27
S206T* 4.40 +/- 0.49
I228A* 1.40 +/- 0.30
I228N 0.30 +/- 0.05
D229A* 3.80 +/- 0.26
D229E* 0.11 +/- 0.03
I230A 0.30 +/- 0.10
I230N* 1.70 +/- 0.40
Y234A* NB
Y234F 1.30 +/- 0.36

NB, No binding

* significantly different from the WT 5-HT3A receptor

Thompson AJ, Price KL, Reeves DC, Chan SL, Chau PL, Lummis SC(2005). Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding.The Journal of Biological Chemistry 280(21):20476-82

back to top
go back to 5-HT3A

Previous Next